Natus Medical Deferred Revenue Trend

Natus Medical Incorporated -- USA Stock  

USD 39.05  1.45  3.86%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 142, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 30.0252. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Deferred Revenue of Natus Medical Incorporated with missing and latest data points interpolated. A component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue, including sales, license fees, and royalties, but excluding interest income.
Deferred Revenue  10 Years Trend  
Slightly volatile
 Deferred Revenue 

Natus Medical Deferred Revenue Over Time

2015-12-31  11,311,000 
2016-12-31  23,346,000 
2017-12-31  18,240,526 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  9,718,544
Geometric Mean  6,750,884
Coefficient Of Variation  68.86
Mean Deviation  5,430,377
Median  11,311,000
Standard Deviation  6,692,238
Range  23,034,000
R Value  0.91
R Squared  0.83
Significance  0.00003784
Slope  1,690,880

Currently Trending

Purchased over 100 shares of
few hours ago ago
Traded for 0.128
Purchased one share of
few hours ago ago
Traded for 16850.6992
Purchased few shares of
few hours ago ago
Traded for 56.95